ID   PHKG2_HUMAN             Reviewed;         406 AA.
AC   P15735; A8K0C7; B4DEB7; E9PEU3; P11800;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   12-OCT-2022, entry version 226.
DE   RecName: Full=Phosphorylase b kinase gamma catalytic chain, liver/testis isoform;
DE            Short=PHK-gamma-LT;
DE            Short=PHK-gamma-T;
DE            EC=2.7.11.19;
DE   AltName: Full=PSK-C3;
DE   AltName: Full=Phosphorylase kinase subunit gamma-2;
GN   Name=PHKG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2915644; DOI=10.1210/mend-3-1-110;
RA   Hanks S.K.;
RT   "Messenger ribonucleic acid encoding an apparent isoform of phosphorylase
RT   kinase catalytic subunit is abundant in the adult testis.";
RL   Mol. Endocrinol. 3:110-116(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=9384616; DOI=10.1093/hmg/7.1.149;
RA   Burwinkel B., Shiomi S., Al Zaben A., Kilimann M.W.;
RT   "Liver glycogenosis due to phosphorylase kinase deficiency: PHKG2 gene
RT   structure and mutations associated with cirrhosis.";
RL   Hum. Mol. Genet. 7:149-154(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 129-273.
RX   PubMed=2948189; DOI=10.1073/pnas.84.2.388;
RA   Hanks S.K.;
RT   "Homology probing: identification of cDNA clones encoding members of the
RT   protein-serine kinase family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:388-392(1987).
RN   [7]
RP   INVOLVEMENT IN GSD9C.
RX   PubMed=9245685; DOI=10.1006/bbrc.1997.7006;
RA   van Beurden E.A., de Graaf M., Wendel U., Gitzelmann R., Berger R.,
RA   van den Berg I.E.;
RT   "Autosomal recessive liver phosphorylase kinase deficiency caused by a
RT   novel splice-site mutation in the gene encoding the liver gamma subunit
RT   (PHKG2).";
RL   Biochem. Biophys. Res. Commun. 236:544-548(1997).
RN   [8]
RP   FUNCTION, AND STRUCTURE.
RX   PubMed=10487978; DOI=10.2741/brushia;
RA   Brushia R.J., Walsh D.A.;
RT   "Phosphorylase kinase: the complexity of its regulation is reflected in the
RT   complexity of its structure.";
RL   Front. Biosci. 4:D618-D641(1999).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-345, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 6-293 IN COMPLEX WITH INHIBITOR.
RG   Structural genomics consortium (SGC);
RT   "Structure of human phosphorylase kinase, gamma 2.";
RL   Submitted (FEB-2011) to the PDB data bank.
RN   [13]
RP   VARIANTS GSD9C GLU-106 AND GLU-189.
RX   PubMed=8896567; DOI=10.1038/ng1196-337;
RA   Maichele A.J., Burwinkel B., Maire I., Sovik O., Kilimann M.W.;
RT   "Mutations in the testis/liver isoform of the phosphorylase kinase gamma
RT   subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in
RT   humans.";
RL   Nat. Genet. 14:337-340(1996).
RN   [14]
RP   VARIANTS GSD9C LYS-157 AND ASN-215.
RX   PubMed=12930917; DOI=10.1203/01.pdr.0000088069.09275.10;
RA   Burwinkel B., Rootwelt T., Kvittingen E.A., Chakraborty P.K.,
RA   Kilimann M.W.;
RT   "Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with
RT   mutations in the PHKG2 gene.";
RL   Pediatr. Res. 54:834-839(2003).
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-317.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Catalytic subunit of the phosphorylase b kinase (PHK), which
CC       mediates the neural and hormonal regulation of glycogen breakdown
CC       (glycogenolysis) by phosphorylating and thereby activating glycogen
CC       phosphorylase. May regulate glycogeneolysis in the testis. In vitro,
CC       phosphorylates PYGM (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:10487978}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 ATP + phosphorylase b = 2 ADP + phosphorylase a.;
CC         EC=2.7.11.19;
CC   -!- SUBUNIT: Hexadecamer of 4 heterotetramers, each composed of alpha,
CC       beta, gamma, and delta subunits. Alpha (PHKA1 or PHKA2) and beta (PHKB)
CC       are regulatory subunits, gamma (PHKG1 or PHKG2) is the catalytic
CC       subunit, and delta is calmodulin. {ECO:0000269|Ref.12}.
CC   -!- INTERACTION:
CC       P15735; P43356: MAGEA2B; NbExp=3; IntAct=EBI-1383819, EBI-5650739;
CC       P15735; P46019: PHKA2; NbExp=7; IntAct=EBI-1383819, EBI-1642846;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P15735-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P15735-2; Sequence=VSP_041858, VSP_041859;
CC   -!- DISEASE: Glycogen storage disease 9C (GSD9C) [MIM:613027]: A metabolic
CC       disorder manifesting in infancy with hepatomegaly, growth retardation,
CC       hypotonia, liver dysfunction, and elevated plasma aminotransferases and
CC       lipids. These symptoms improve with age in most cases; however, some
CC       patients may develop hepatic fibrosis or cirrhosis.
CC       {ECO:0000269|PubMed:12930917, ECO:0000269|PubMed:8896567,
CC       ECO:0000269|PubMed:9245685}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M31606; AAA36442.1; -; mRNA.
DR   EMBL; Y11950; CAA72694.1; -; Genomic_DNA.
DR   EMBL; Y11951; CAA72694.1; JOINED; Genomic_DNA.
DR   EMBL; AK289492; BAF82181.1; -; mRNA.
DR   EMBL; AK293551; BAG57028.1; -; mRNA.
DR   EMBL; AC106886; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002541; AAH02541.1; -; mRNA.
DR   EMBL; M14503; AAA36518.1; -; mRNA.
DR   CCDS; CCDS10690.1; -. [P15735-1]
DR   CCDS; CCDS54002.1; -. [P15735-2]
DR   PIR; A40069; KIHUCT.
DR   RefSeq; NP_000285.1; NM_000294.2. [P15735-1]
DR   RefSeq; NP_001165903.1; NM_001172432.1. [P15735-2]
DR   PDB; 2Y7J; X-ray; 2.50 A; A/B/C/D=6-293.
DR   PDBsum; 2Y7J; -.
DR   AlphaFoldDB; P15735; -.
DR   SMR; P15735; -.
DR   BioGRID; 111279; 78.
DR   IntAct; P15735; 53.
DR   MINT; P15735; -.
DR   STRING; 9606.ENSP00000455607; -.
DR   BindingDB; P15735; -.
DR   ChEMBL; CHEMBL2349; -.
DR   DrugCentral; P15735; -.
DR   GuidetoPHARMACOLOGY; 2147; -.
DR   GlyGen; P15735; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P15735; -.
DR   PhosphoSitePlus; P15735; -.
DR   BioMuta; PHKG2; -.
DR   DMDM; 125536; -.
DR   EPD; P15735; -.
DR   jPOST; P15735; -.
DR   MassIVE; P15735; -.
DR   MaxQB; P15735; -.
DR   PaxDb; P15735; -.
DR   PeptideAtlas; P15735; -.
DR   PRIDE; P15735; -.
DR   ProteomicsDB; 53208; -. [P15735-1]
DR   ProteomicsDB; 53209; -. [P15735-2]
DR   Antibodypedia; 13792; 386 antibodies from 29 providers.
DR   DNASU; 5261; -.
DR   Ensembl; ENST00000424889.7; ENSP00000388571.3; ENSG00000156873.16. [P15735-2]
DR   Ensembl; ENST00000563588.6; ENSP00000455607.1; ENSG00000156873.16. [P15735-1]
DR   GeneID; 5261; -.
DR   KEGG; hsa:5261; -.
DR   MANE-Select; ENST00000563588.6; ENSP00000455607.1; NM_000294.3; NP_000285.1.
DR   UCSC; uc021tgo.3; human. [P15735-1]
DR   CTD; 5261; -.
DR   DisGeNET; 5261; -.
DR   GeneCards; PHKG2; -.
DR   GeneReviews; PHKG2; -.
DR   HGNC; HGNC:8931; PHKG2.
DR   HPA; ENSG00000156873; Tissue enriched (testis).
DR   MalaCards; PHKG2; -.
DR   MIM; 172471; gene.
DR   MIM; 613027; phenotype.
DR   neXtProt; NX_P15735; -.
DR   OpenTargets; ENSG00000156873; -.
DR   Orphanet; 264580; Glycogen storage disease due to liver phosphorylase kinase deficiency.
DR   PharmGKB; PA33272; -.
DR   VEuPathDB; HostDB:ENSG00000156873; -.
DR   eggNOG; KOG0599; Eukaryota.
DR   GeneTree; ENSGT00940000160435; -.
DR   InParanoid; P15735; -.
DR   OrthoDB; 330091at2759; -.
DR   PhylomeDB; P15735; -.
DR   TreeFam; TF320349; -.
DR   BioCyc; MetaCyc:HS08155-MON; -.
DR   BRENDA; 2.7.11.19; 2681.
DR   PathwayCommons; P15735; -.
DR   Reactome; R-HSA-70221; Glycogen breakdown (glycogenolysis).
DR   SignaLink; P15735; -.
DR   SIGNOR; P15735; -.
DR   BioGRID-ORCS; 5261; 9 hits in 1114 CRISPR screens.
DR   ChiTaRS; PHKG2; human.
DR   GeneWiki; PHKG2; -.
DR   GenomeRNAi; 5261; -.
DR   Pharos; P15735; Tchem.
DR   PRO; PR:P15735; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; P15735; protein.
DR   Bgee; ENSG00000156873; Expressed in left testis and 127 other tissues.
DR   ExpressionAtlas; P15735; baseline and differential.
DR   Genevisible; P15735; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005964; C:phosphorylase kinase complex; TAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0004689; F:phosphorylase kinase activity; TAS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB.
DR   GO; GO:0050321; F:tau-protein kinase activity; TAS:UniProtKB.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   GO; GO:0005978; P:glycogen biosynthetic process; IEA:InterPro.
DR   GO; GO:0005980; P:glycogen catabolic process; IEA:Ensembl.
DR   GO; GO:0005977; P:glycogen metabolic process; TAS:ProtInc.
DR   GO; GO:0045819; P:positive regulation of glycogen catabolic process; TAS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002291; Phosph_kin_gamma.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01049; PHOSPHBKNASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Calmodulin-binding;
KW   Carbohydrate metabolism; Disease variant; Glycogen metabolism;
KW   Glycogen storage disease; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..406
FT                   /note="Phosphorylase b kinase gamma catalytic chain,
FT                   liver/testis isoform"
FT                   /id="PRO_0000086512"
FT   DOMAIN          24..291
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          306..330
FT                   /note="Calmodulin-binding (domain-N)"
FT                   /evidence="ECO:0000250"
FT   REGION          346..370
FT                   /note="Calmodulin-binding (domain-C)"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        153
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         30..38
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         53
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         345
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         362..374
FT                   /note="VKKGEQQNRAALF -> IRKQWIGKLMACV (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041858"
FT   VAR_SEQ         375..406
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041859"
FT   VARIANT         106
FT                   /note="V -> E (in GSD9C; dbSNP:rs137853589)"
FT                   /evidence="ECO:0000269|PubMed:8896567"
FT                   /id="VAR_009517"
FT   VARIANT         157
FT                   /note="E -> K (in GSD9C; dbSNP:rs752961445)"
FT                   /evidence="ECO:0000269|PubMed:12930917"
FT                   /id="VAR_020854"
FT   VARIANT         189
FT                   /note="G -> E (in GSD9C; dbSNP:rs137853588)"
FT                   /evidence="ECO:0000269|PubMed:8896567"
FT                   /id="VAR_009518"
FT   VARIANT         215
FT                   /note="D -> N (in GSD9C; dbSNP:rs767427889)"
FT                   /evidence="ECO:0000269|PubMed:12930917"
FT                   /id="VAR_020855"
FT   VARIANT         247
FT                   /note="E -> G (in dbSNP:rs34006569)"
FT                   /id="VAR_051658"
FT   VARIANT         317
FT                   /note="A -> T (in dbSNP:rs759992249)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040996"
FT   CONFLICT        146
FT                   /note="A -> P (in Ref. 6; AAA36518)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        176
FT                   /note="C -> S (in Ref. 6; AAA36518)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        179
FT                   /note="E -> D (in Ref. 6; AAA36518)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        212..214
FT                   /note="KEV -> LVD (in Ref. 6; AAA36518)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        221
FT                   /note="V -> E (in Ref. 6; AAA36518)"
FT                   /evidence="ECO:0000305"
FT   HELIX           13..23
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   STRAND          24..32
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   STRAND          34..43
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   TURN            44..46
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   STRAND          49..56
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   HELIX           64..84
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   STRAND          93..107
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   HELIX           115..122
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   HELIX           127..146
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   HELIX           156..158
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   STRAND          159..161
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   STRAND          167..169
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   HELIX           191..193
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   HELIX           196..201
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   HELIX           214..228
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   HELIX           238..247
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   HELIX           254..257
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   STRAND          258..260
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   HELIX           262..271
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   TURN            276..278
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   HELIX           282..287
FT                   /evidence="ECO:0007829|PDB:2Y7J"
FT   HELIX           289..291
FT                   /evidence="ECO:0007829|PDB:2Y7J"
SQ   SEQUENCE   406 AA;  46442 MW;  E991CFF2D3D70F60 CRC64;
     MTLDVGPEDE LPDWAAAKEF YQKYDPKDVI GRGVSSVVRR CVHRATGHEF AVKIMEVTAE
     RLSPEQLEEV REATRRETHI LRQVAGHPHI ITLIDSYESS SFMFLVFDLM RKGELFDYLT
     EKVALSEKET RSIMRSLLEA VSFLHANNIV HRDLKPENIL LDDNMQIRLS DFGFSCHLEP
     GEKLRELCGT PGYLAPEILK CSMDETHPGY GKEVDLWACG VILFTLLAGS PPFWHRRQIL
     MLRMIMEGQY QFSSPEWDDR SSTVKDLISR LLQVDPEARL TAEQALQHPF FERCEGSQPW
     NLTPRQRFRV AVWTVLAAGR VALSTHRVRP LTKNALLRDP YALRSVRHLI DNCAFRLYGH
     WVKKGEQQNR AALFQHRPPG PFPIMGPEEE GDSAAITEDE AVLVLG
//
